Spot on. No one knows who or when the tech. will be approved. A lot of competition out there attempting to do it. And if they rush through it. One can see lawsuits coming. Not something a company wants to be involved in. Blood oxygen should be approved if claims and testing satisfy the FDA.
I think blood pressure approval would be a huge factor in upping sales as well.
The bigger picture will be what kind of deal LQMT has agreed to. Will it be all hype like the golf deal or will it be an actual per product part ordered?
I’m leaning towards a more favorable outcome right now. In the meantime since no impacting 8K has been released from any new deal, I can see LQMT after the upcoming 10K heading south again. Could be an opportunity to add or for non investors to buy in, in lieu of the potential for later this year.